Bio/Pharmaceutical Outsourcing Report, March 2026

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2950
Buy Report Download FREE Resources

Published: April 06, 2026 Report Code: GDPB087-ST

Select Item

Bio/pharmaceutical outsourcing trends: track CMO deals, contracts, M&A, regulatory updates and industry developments with GlobalData’s monthly report.

Stay Ahead in the Pharmaceutical Outsourcing Market

The pharmaceutical outsourcing landscape is constantly evolving, shaped by deal activity, regulatory changes, and shifting manufacturing priorities.

This monthly report delivers a clear view of the latest developments impacting Contract Manufacturing Organizations (CMOs). It tracks outsourcing contracts, M&A activity, financing deals, and facility-level updates, alongside insights into business conditions and emerging risks.

From GMP inspections to site openings and technology investments, the report keeps you informed on what is shaping the outsourcing ecosystem.

Report Value Proposition – Why This Matters for You

This is not just a news summary. It’s a structured intelligence tool designed to help you stay ahead of market shifts.

You can use it to:

  • Track new outsourcing contracts and service agreements
  • Monitor mergers, acquisitions, and financing activity
  • Identify emerging opportunities and threats in manufacturing
  • Stay updated on regulatory developments and GMP inspections
  • Strengthen supplier selection and competitive intelligence

In addition, the report is backed by GlobalData’s proprietary databases and expert analysis.

Key Insights in Pharmaceutical Outsourcing Trends

Outsourcing activity continues to evolve, driven by changing clinical pipelines and regulatory decisions.

M&A and financing activity remain central to shaping the competitive landscape of CMOs.

Facility-level developments, including site expansions, closures, and technology investments, reflect ongoing capacity adjustments.

At the same time, supply chain disruptions and regulatory changes continue to influence operational strategies across the industry.
Algeria Power Market Outlook to 2035

Scope

What You Will Learn

The report provides a structured view of the pharmaceutical outsourcing market, including:

  • Latest outsourcing contracts and service agreements

  • M&A and financing activity among CMOs

  • Regulatory updates and GMP inspection outcomes

  • Facility-level developments and capacity changes

  • Emerging risks, supply chain challenges, and innovation trends

Target Buyers for This Report

This report is designed for decision-makers across the pharmaceutical ecosystem:

  • CMO executives and strategic planners

  • Sourcing and procurement professionals

  • Pharmaceutical and biotech companies

  • Investors, advisors, and consultants

If you are tracking outsourcing trends or evaluating manufacturing strategies, this report will support your decisions.

How Companies Use This Report

  • CMO executives and strategy teams
    Support strategic planning and market positioning

  • Sourcing and procurement teams
    Evaluate suppliers and manage outsourcing decisions

  • Pharmaceutical and biotech companies
    Track manufacturing trends and partnership opportunities

  • Investors and consultants
    Identify investment targets and market shifts

As a result, you can stay competitive in a rapidly changing outsourcing environment.

Reasons to Buy

Track Market Activity with Monthly Intelligence

This report provides a comprehensive monthly update across key areas of the outsourcing market.

You gain visibility into:

  • New outsourcing contracts and partnerships

  • M&A deals and financing activity

  • Clinical and regulatory developments impacting manufacturing

  • Facility-level updates, including inspections and investments

  • Supply chain challenges and emerging risks

This enables faster, more informed decision-making in a dynamic market.

Built on Trusted Data and Expert Analysis

This report is powered by GlobalData’s integrated datasets and analyst expertise.

  • Combines data across deals, companies, drugs, clinical trials, and financials

  • Supported by continuous news tracking and expert interpretation

  • Designed for actionable, real-time market intelligence

Therefore, you can rely on the insights to guide strategic decisions.

Act Now to Stay Ahead of Outsourcing Trends

The pharmaceutical outsourcing market is fast-moving and increasingly complex.

This report helps you stay updated on deals, disruptions, and opportunities shaping the industry.

Therefore, if you want to stay ahead of competitors and make informed decisions, now is the time to act.

1315 Capital LLC
3P Biopharmaceuticals SLU
3SBio Inc
Aenova Holding GmbH
Agilent Technologies Inc
AGC Biologics Inc
Agno Pharmaceuticals LLC
Almac Group Ltd
Alpine Immune Sciences Inc
Ampersand Capital Partners
Andelyn Biosciences Inc
Anupam Rasayan India Ltd
Apozeal Pharmaceuticals Inc
Ardena Holding NV
Ardena Sodertalje AB
Atamyo Therapeutics SAS
Avid Bioservices Inc
Axplora Group GmbH
Bayer
Bavarian Nordic AS
Bespak Ltd
Beta Drugs Ltd
BioMarin Pharmaceutical Inc
Biogen Inc
Bilthoven Biologicals BV
BlackRock Inc
Bliss GVS Pharma Ltd
BNC Korea Co Ltd
Boehringer Ingelheim
Boehringer Ingelheim Pharma GmbH Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Bora Pharmaceuticals Co Ltd
Bristol-Myers Squibb Co
C3i Center Inc
Catalent Inc
Catalent CTS LLC
Cellares Corp
Cell and Gene Therapy Catapult
Charles River Laboratories International Inc
Chiesi USA Inc
CStone Pharmaceuticals Co Ltd
CS Analytical
C-squared Pharma Sarl
Codis
Coating Place Inc
Coriolis Pharma Research GmbH
Dottikon Exclusive Synthesis AG
EDE / Emirates Drug Establishment
Eckert Ziegler SE
Earth Vision Bio Solutions, Inc
EirGen Pharma Ltd
Elpida Therapeutics
Eli Lilly and Co
EMA / European Medicines Agency
Eton Pharmaceuticals Inc
Esteve Pharmaceuticals SA
Esteve Quimica SA
Eurofins Scientific SE
Evotec
Exmoor Pharma Concepts Ltd
Flamma SpA
Forma Life Sciences
FUJIFILM Biotechnologies USA Inc
GSK plc
Genetix Biotherapeutics Inc
GlobalData Plc
Haleos Labs Ltd
Halo Pharma Inc
Hindustan Laboratories
Hovione FarmaCiencia SA
IDA Waterford Business Park
IDT Biologika GmbH
ImmunityBio Inc
Immedica Pharma AB
Informa
Ipsen SA
Jazz Pharmaceuticals UK Ltd
Janssen Biotech Inc
Janssen-Cilag International NV
Jetpharma SA
Jiangsu Jiaerke Pharmaceutical Group Co Ltd
Just Evotec Biologics Inc
Jubilant Generics Ltd
Jubilant Pharmaceuticals Incorporation
Kenox Pharmaceuticals Inc
Kymos Pharma Services SL
Kyron Bio SAS
Lek Pharmaceuticals dd
Les Laboratoires Servier SAS
Lilly Gateway Labs
Lonza Group Ltd
Locus Cell Co Ltd
MB Funds
Merck Co Inc
Merck Sharp Dohme UK Ltd
Merck & Co.
Meta? no
MilliporeSigma
Molecular Partners AG
MoonLake Immunotherapeutics
Nano? no
Nanologica AB
National Cancer Institute Instituto Nacional de Cancerología
Nivian Lifesciences Private Limited
Nikon CeLL innovation Co Ltd
Norgine BV
Novo Nordisk AS
Novo Nordisk Ltd
OncoC4 Inc
Organon Co
Patheon
Patheon France SAS
Patheon NV
PCI Pharma Services
Pfizer Inc
Pharmaron
Pharmatory Ltd
Pleiades Therapeutics
Pocono Pharmaceutical Inc
Praxis Packaging Solutions
ProBioGen AG
Purna Pharmaceuticals NV
Quell Therapeutics Ltd
Quotient Sciences Ltd
Rentschler Biopharma SE
Rechon Life Science
Roche
Roche Products Ltd
RoosterBio Inc
Samsung Biologics America, Inc.
Samsung Biologics Co Ltd
Sandoz GmbH
Sanofi
Sanofi-Aventis US LLC
Sanofi UK
Satellos Bioscience Inc
Sharp Packaging Services LLC
Shize Biotech
Siegfried Holding AG
Simtra US LLC
SK Pharmteco Inc
Southwest Research Institute
Sterling Pharma Solutions
Sterling Pharma Solutions Ltd
Sun Pharmaceutical Industries Ltd
Sun Pharma UK Ltd
Symbiotec Pharmalab Pvt Ltd
Takeda
Tevogen Bio Holdings Inc
TerSera Therapeutics LLC
Therna Biosciences Inc
Tulex Pharmaceuticals Inc
Unimedic AB
University of Wisconsin Madison
Vetter Pharma-Fertigung GmbH Co KG
Vicebio Ltd
Viralgen Vector Core SL
Vista Pharmaceuticals Ltd
WuXi Biologics Cayman Inc
WuXi Biologics Co Ltd
WuXi STA Shanghai Co Ltd
WuXi XDC Cayman Inc
Yposkesi SAS
Zhejiang Xianju Junye Pharmaceutical Co Ltd
Zydus Lifesciences Ltd

Table of Contents

Table of Contents

1 Industry Trends

1.1 Eli Lilly expands manufacturing in China and Japan as GLP-1 demand keeps rising

1.1.1 Building local capacity for oral GLP-1s in China and expanding domestic production in Japan

1.1.2 Why these investments matter

1.1.3 How this fits with US reshoring rules

1.1.4 The bigger strategy

1.2 Rising geopolitical tensions in the Middle East threaten regional pharmaceutical supply chain and drug shortages

1.2.1 Pharmaceutical impact

1.2.2 Industry response

1.2.3 Country response

1.2.4 Outlook and implications

2 Industry Analysis

2.1 Contract service agreements

2.2 Contract manufacturing – opportunities and threats

2.3 Quarterly mergers, acquisitions, and financing – Q1 2026

3 Value Chain

3.1 API chemical

3.2 API biologics – cell, gene, vaccine, and virus

3.3 API biologics – protein and peptide

3.4 Commercial dose manufacturing and packaging

3.5 Clinical dose manufacturing

3.6 Analytical services

4 About GlobalData

5 About the Authors

6 Contact Us

Table

Table 1: Contract service agreements

Table 2: Contract manufacturing: opportunities and threats – potentially positive

Table 3: Contract manufacturing: opportunities and threats – potentially negative

Table 4: Mergers, acquisitions, and financing – Q1 2026

Figures

Figure 1: Contract service agreements by deal geography, by volume

Figure 2: Deals by deal geography, by volume – mergers, acquisitions, and financing

Figure 3: The contract manufacturing value chain

Bio/Pharmaceutical Outsourcing Report, March 2026 standard reports
Currency USD
$2,950

Can be used by individual purchaser only

Most Popular
$5,900

Can be shared by unlimited users within one corporate location e.g. a regional office

$8,850

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Bio/Pharmaceutical Outsourcing Report, March 2026 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Contract Manufacturers reports
Pharmaceuticals
New
Asthma: Global Clinical Trials Review, 2026
$3,450 | April 2026
Pharmaceuticals
New
Rheumatic Disorders: Global Clinical Trials Review, 2026
$3,450 | April 2026
Pharmaceuticals
New
Alzheimer's Disease: Global Clinical Trials Review, 2026
$3,450 | April 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bio/Pharmaceutical Outsourcing Report, March 2026 in real time.

  • Access a live Bio/Pharmaceutical Outsourcing Report, March 2026 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more